Volume 67, Issue 3 pp. 312-320

Original Article

Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children

I. Stelmach,

I. Stelmach

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

I. Kaluzińska-Parzyszek,

I. Kaluzińska-Parzyszek

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

J. Jerzynska,

J. Jerzynska

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

P. Stelmach,

P. Stelmach

Medical University of Lodz, Lodz

Search for more papers by this author

W. Stelmach,

W. Stelmach

Department of Social and Preventive Medicine, Medical University of Lodz, Lodz, Poland

Search for more papers by this author

P. Majak,

P. Majak

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

I. Stelmach,

I. Stelmach

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

I. Kaluzińska-Parzyszek,

I. Kaluzińska-Parzyszek

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

J. Jerzynska,

J. Jerzynska

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

P. Stelmach,

P. Stelmach

Medical University of Lodz, Lodz

Search for more papers by this author

W. Stelmach,

W. Stelmach

Department of Social and Preventive Medicine, Medical University of Lodz, Lodz, Poland

Search for more papers by this author

P. Majak,

P. Majak

Department of Pediatrics and Allergy, Medical University of Lodz, N Copernicus Hospital, Lodz

Search for more papers by this author

First published: 06 December 2011

https://doi.org/10.1111/j.1398-9995.2011.02758.x

Citations: 53

Iwona Stelmach, Department of Pediatrics and Allergy, N Copernicus Hospital, 62 Pabianicka Street, 93-513, Lodz, Poland.
Tel.: 48 42 689 59 72
Fax: 48 42 689 59 73
E-mail: [email protected]

Edited by: Thomas Bieber

Share a link

Email
Wechat
Bluesky

Abstract

To cite this article: Stelmach I, Kaluzińska-Parzyszek I, Jerzynska J, Stelmach P, Stelmach W, Majak P. Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children. Allergy 2012; 67: 312–320.

Background: One of the most important aspects of sublingual immunotherapy (SLIT) is the regimen of administration. The aim of the study was to compare the efficacy and the safety of SLIT given pre-coseasonally (starting before the pollen season and continuing until the end of it) and continuously (all year round, independent of the pollen season) in children allergic to grass pollen.

Methods: Sixty children aged 6–18, sensitive only to grass pollen, with rhinitis (20 patients had concomitant asthma) participated in the 2-year prospective, randomized, double-blind, placebo-controlled trial.

Results: Both pre-coseasonal and continuous SLIT were associated with a substantial reduction in the combined symptoms/medication score when compared with placebo; there were no significant differences between the regimens (mean difference: 18.1 ± 12.4, P > 0.05). Similar changes were observed in the total symptoms score. Pre-coseasonal therapy, compared with continuous, was more effective in the reduction of nasal symptoms (mean difference: −18.0 ± 2.5, P = 0.006). We did not observe significant differences in medication, ocular, and asthma scores between the regimens. We did not observe changes in morning PEF, FEV1, and PD20 in any of the three groups nor between the groups throughout the study. We showed a significant decrease in FeNO level comparable in both active groups. There were no differences between groups in the induction of CD4CD25Foxp3-positive cells in peripheral blood during the study.

Conclusion: Both protocols were effective compared with placebo and showed similar decreases for combined symptoms/medication score and all secondary endpoints, with the exception of nasal symptoms that were lower in the pre-coseasonal group.

References

1 Calderón MA, CasaleTB, TogiasA, BousquetJ, DurhamSR, DemolyP. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol2011; 127: 30–38.
10.1016/j.jaci.2010.08.024
PubMed Web of Science® Google Scholar
2 Serra HM, AlignaniDO, PassalacquaG, CanonicaGW, CorreaSG. What do we need to learn to optimize the SLIT alternative. Allerg Immunol (Paris)2006; 38: 158–165.
CAS PubMed Google Scholar
3 Durham SR, YangWH, PedersenMR, JohansenR, RakS. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol2006; 117: 802–809.
10.1016/j.jaci.2005.12.1358
CAS PubMed Web of Science® Google Scholar
4 Passalacqua G, CanonicaGW. Sublingual or injection immunotherapy: the final answer?Allergy2004; 59: 37–38.
10.1046/j.1398-9995.2003.00397.x
CAS PubMed Web of Science® Google Scholar
5 Calderon MA, BirkAO, AndersenJS, DurhanSR. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy2007; 62: 958–961.
10.1111/j.1398-9995.2007.01416.x
CAS PubMed Web of Science® Google Scholar
6 Penagos M, PassalacquaG, CompalatiE, Baena-CagnaniCE, OrozcoS, PedrozaA_et al.Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest2008; 133: 599–609.
10.1378/chest.06-1425
CAS PubMed Web of Science® Google Scholar
7 Bousquet J, KhaltaevN, CruzAA, DenburgJ, FokkensWJ, TogiasAet al.Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN*and AllerGen**). Allergy2008; 63: 8–160.
10.1111/j.1398-9995.2007.01620.x
CAS PubMed Web of Science® Google Scholar
8 Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NIH publication no. 02-3659. January 1995, updated 2008. Available at http://www.ginasthma.com/download.asp?intId=345 Accessed 2011.
Google Scholar
9 Alvarez-Cuesta E, BousquetJ, CanonicaGW, DurhamSR, MallingHJ, ValovirtaEet al.EAACI, Immunotherapy Task Force. Allergy2006; 61(Suppl 82): 1–20.
10.1111/j.1398-9995.2006.01219_1.x
PubMed Web of Science® Google Scholar
10 Wasserfallen JB, GoldK, SchulmanKA, BaraniukJN. Development and validation of a rhinoconjunctivitis and asthma symptom score for use as an outcome measure in clinical trials. J Allergy Clin Immunol1997; 100: 16–22.
10.1016/S0091-6749(97)70189-1
CAS PubMed Web of Science® Google Scholar
11 Stelmach I, Kaczmarek-WoźniakJ, MajakP, Olszowiec-ChlebnaM, JerzynskaJ. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen. Clin Exp Allergy2009; 39: 401–408.
10.1111/j.1365-2222.2008.03159.x
CAS PubMed Web of Science® Google Scholar
12 Miller MR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, CoatesAet al.ATS/ERS TaskForce. Standardisation of spirometry. Eur Respir J2005; 26: 319–338.
10.1183/09031936.05.00034805
CAS PubMed Web of Science® Google Scholar
13 Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med1999; 160: 2104–2117.
10.1164/ajrccm.160.6.ats8-99
CAS PubMed Web of Science® Google Scholar
14 Crellin NK, GarciaRV, HadisfarO, AllanSE, SteinerTS, LevingsMK. Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+ CD25+ T regulatory cells. J Immunol2005; 175: 8051–8059.
10.4049/jimmunol.175.12.8051
CAS PubMed Web of Science® Google Scholar
15 Bousquet J, SchünemannHJ, BousquetPJ, BachertC, CanonicaGW, CasaleTBet al.How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy2011; 66: 765–774.
10.1111/j.1398-9995.2011.02590.x
CAS PubMed Web of Science® Google Scholar
16 Penagos M, CompalatiE, TarantiniF, Baena-CagnaniR, HuertaJ, PassalacquaGet al.Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol2006; 97: 141–148.
10.1016/S1081-1206(10)60004-X
CAS PubMed Web of Science® Google Scholar
17 Lombardi C, IncorvaiaC, BragaM, SennaG, CanonicaGW, PassalacquaG. Administration regimens for sublingual immunotherapy to pollen allergens: what do we know?Allergy2009; 64: 849–854.
10.1111/j.1398-9995.2009.02063.x
CAS PubMed Web of Science® Google Scholar
18 Pajno GB, CaminitiL, CrisafulliG, VitaD, ValenziseM, De LucaRet al.Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: a randomized controlled study. Pediatr Allergy Immunol2011; [Epub ahead of print].
10.1111/j.1399-3038.2011.01196.x
Web of Science® Google Scholar
19 Xystrakis E, UrryZ, HawrylowiczCM. Regulatory T cell therapy as individualized medicine for asthma and allergy. Curr Opin Allergy Clin Immunol2007; 7: 535–541.
10.1097/ACI.0b013e3282f14d7c
PubMed Web of Science® Google Scholar
20 Radulovic S, JacobsonMR, DurhamSR, Nouri-AriaKT. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol2008; 121: 1467–1472.
10.1016/j.jaci.2008.03.013
CAS Web of Science® Google Scholar
21 Scadding G, DurhamS. Mechanisms of sublingual immunotherapy. J Asthma2009; 46: 322–334.
10.1080/02770900902785729
CAS PubMed Web of Science® Google Scholar
22 Akdis CA, AkdisM. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol2011; 127: 18–27.
10.1016/j.jaci.2010.11.030
CAS PubMed Web of Science® Google Scholar
23 Nieminen K, ValovirtaE, SavolainenJ. Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapy. Pediatr Allergy Immunol2010; 21: 174–184.
10.1111/j.1399-3038.2009.00920.x
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume67, Issue3

March 2012

Pages 312-320

Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children

Abstract

References

Citing Literature

References

Related

Information